NPPB and cancer: The current strategy for the surveillance of anti-cancer chemotherapy-related cardiotoxicity includes regular monitoring through imaging techniques (e.g., echocardiography) and cardiac biomarkers (e.g., troponins and BNP/NT-proBNP) that detect early signs of heart damage.